NTERLEUKIN-2 (IL-2) is known to stimulate the proliferation and differentiation of T cells and to affect the responses of other cell types of the immune system, such as natural killer cells, monocytes, and B cells through interactions with the interleukin-2 receptor (IL-2R)."6 Recently, the IL-2R was shown to be present on neutrophils, and a number of functional responses mediated by this cell type were found to be affected by IL-2. IL-2 enhances antifungal a~tivity,~ prolongs the neutrophil's lifespan through inhibition of apoptosis,' and leads to the increased production of tumor necrosis factor-a (TNF-a) and IL-8.9,'0 It decreases Fcy receptor expression",'2 and reduces the chemotactic response of neutrophils induced by TNF-a." These latter effects of IL-2 on neutrophils are believed to be responsible for the increased susceptibility to sepsis of patients undergoing IL-2 therapy." Finally, considerable interest has been generated in understanding E-2-neutrophil interactions in view of the observation that tumors transfected with the IL-2 gene become heavily surrounded by neutrophils in vivo.I3 In some tumors, the antitumoral activity of IL-2 was believed to be mediated, at least in part, by neutrophil^.'^"^ It is generally accepted that neutrophils play roles in host responses that extend beyond their capacities to function as phagocytes and cell-releasing cytotoxic comp~unds.'~ In particular, they are considered to be capable of synthesizing de novo host defense proteins, such as cytokines, that have the potential to perform active functions in the afferent and efferent limbs of the immune Previous studies nine, however, IL-2 exerted no similar effect. Furthermore, the study of a large number of normal subjects (n = 55) showed reproducible categories of responders (low, intermediate, and high). The binding of IL-2 to the IL-2R complex on human neutrophils increased on GM-CSF-stimulated neutrophils compared with unstimulated cells. However, no increase in the level of expression of either the a or p chains of this receptor complex was observed. This finding suggests that GM-CSF functionally activates the IL-2R, but does not regulate its level of expression. Finally, we found that human neutrophils constitutively express IL-2Ry chain mRNA and thus have the potential to express the functional IL-2R complex. Our findings on IL-2-neutrophil interactions should lead to new avenues of research in understanding the responses of patients undergoing GM-CSF or IL-2 therapy. 0 1995 by The American Society of Hematology. performed in our laboratory have shown that among a wide range of proinflammatory agonists tested, only a limited number activated de novo synthesis of RNA and proteins in neutrophils, these being granulocyte-macrophage colonystimulating factor (GM-CSF), TNF-a, and formyl-methionyl-leucyl-phenylalanine (FMLP).I9 In particular, IL-2 exerted relatively weak activity, but at that time the possibility was not ruled out that synergistic or enhancement effects between neutrophil agonists might take place. Cytokines are often present simultaneously at sites of inflammation, and modulation of receptor expression or responsiveness by one agonist could influence the ability of a second agent to exert its actions. Therefore, we initiated studies to investigate such potential effects of various neutrophil agonists on gene expression in this cell. We now report that the effects of IL-2 on gene expression in neutrophils are markedly and specifically enhanced by GM-CSF.
MATERIALS AND METHODS
Neutrophil isolation. Neutrophils were isolated from venous blood obtained from normal volunteers by centrifugation over FicollHypaque (Pharmacia Biotech Inc, Quebec, Canada) as previously described." Blood donations were obtained from informed and consenting individuals according to institutionally approved procedures. All cell suspensions contained fewer than 1% monocytes as determined by monoesterase staining, and cell viability was always greater than 99%.
Cytokines. Recombinant human 1L-2 (specific activity of 22 X lo6 U/mg) was provided by Cetus Corporation (Emeryville, CA). Recombinant human GM-CSF (specific activity of 9 X lo6 U/mg) was a gift from the Genetics Institute (Boston, MA).
RNA synthesis assay. This assay was performed by measuring the incorporation of [5-3H] -uridine (Amersham Corp, Oakville, Ontario, Canada) into total RNA essentially as previously described." One hundred microliters of a 5-x-106-cell/mL suspension in RPM1 with 1% autologous serum was incubated in 96-well microtiter plates in the presence of 1 pCi of [5-3H] -uridine along with cytokines for 4 hours at 37°C. 5% CO2 in triplicate. This time point had previously been shown to be optimal.lY Cells were then collected onto horosilicate glass fiber paper by a multiple cell culture harvester (Skatron Instruments Inc. Sterling, VA), and sections of the filter corresponding to each microwell were then punched out and placed in scintillation counting vials in the presence of 4 mL of Aquasol-2 (Dupont New England Nuclear, Boston, MA). Results are expressed as mean cpm (LSE) obtained from studying several normal subjects. Stimula- Protein precipitation was performed in Eppendorf tubes with a final concentration of 70% ethanol for 1 hour at -20°C. Intracellular and extracellular proteins were treated separately. After centrifugation of the precipitates, the pellets were solubilized with the lysis buffer (9.5 mom urea, 2% NP-40 and 5% 0-mercaptoethanol), and 10 mL of each corresponding fraction was placed in scintillation counting vials with 4 mL of Aquasol-2. This was performed to determine the amount of radiolabeled proteins loaded for the migration. Highresolution two-dimensional gel electrophoresis was performed as previously described using the Millipore Investigator 2D Electrophoresis System (Millipore Corp, Bedford, MA). One-dimensional isoelectric focusing was performed using 2% ampholite (1:4, vol/vol, pH 4-8, and pH 3-10). Second-dimensional gels were 12% acrylamide. Gels were dried and exposed for 3 to 5 days at -70°C. Twodimensional gel analysis of proteins was performed with the BioImage 110-S analyzer (Millipore) using the 2D Gel Match Program (Ann Arbor, MI).
Flow cytometry. We determined IL-2R expression by using the relative binding of Fluorokine IL-2 phycoerythrin (PE) and Fluorokine streptavidin-PE (S-PE) according to the manufacturer's instructions (R&D System, Minneapolis, MN), performed with GM-CSFtreated cells (3 X mom) and unstimulated cells incubated for 30 minutes at 37"C, 5% COz. In other experiments, 1 X lo6 neutrophils were dually stained directly with 20 mL of PE-labeled monoclonal antibody to the human IL-2Ra chain (p%) (Becton Dickinson, Mountain View, CA) and 5 mL of fluorescein isothiocyanate-labeled antibody to the human IL-2RP chain of the IL-2R complex (p73 (Endogen, Boston, MA). Staining was performed according to the manufacturer's recommended procedures. Dual-color isotypic stainings were used as negative controls (BioKan Scientific, Mississauga, Ontario). Final flow cytometric analysis was performed by using an EPIC 753 (Coulter, Miami Lakes, FL).
RNA isolation and northern blot analysis. The total RNA was isolated by the RNAzol method (ID-Labs, London, Ontario, Canada), and 15 pg of total RNA was loaded on a 1% agarose denaturing gel and size-fractionated by electrophoresis. Gels were then visualized under ultraviolet (UV) illumination to verify that equal amounts of RNA had been loaded and also to determine the position of the 18s and 28s ribosomal RNA bands. The transfer was performed in 3 hours with the VacuGene TM XL vacuum blotting system according to the manufacturer's specifications (Pharmacia), and was complete for each lane. The IL-2Ry probe was obtained by polymerase chain reaction (PCR) amplification using the two following primers based on the published sequence of the mRNAZ3: 5' GAAGAGCAAGCGCCATGl'TG 3' and 5' CGGl'TCAGGAACAATCGGAG 3'. This step yielded a 1.4-kb fragment, which was purified on a low-melting-point agarose gel. After prehybridization, the membranes were hybridized with random-primed "P-labeled probes according to the Prime-a-Gene Labeling System (Promega, Madison, WI) in 50% formamide overnight at 42°C. The membranes were then washed and exposed to Kodak X-Omat films (Eastman-Kd&, Rochester, NY) with an intensifying screen at -70°C.
RESULTS
Induction of d e novo RNA synthesis in neutrophils. Total RNA synthesis was studied in neutrophils by measuring [S- 3H]-uridine uptake. We incubated IL-2 with neutrophils and observed that the level of incorporation was similar whether the neutrophils were stimulated with IL-2 (from 10 to lo5 U/mL) or not ( Fig IA) . However, we also found that the level of incorporation increased in a dose-dependent manner when the cells were stimulated with a combination of a predetermined optimal but fixed GM-CSF concentration (3 X moVL) and increasing concentrations of IL-2 ( Fig  1A) . Based on these data, we further compared the induction of total RNA synthesis using cells treated with GM-CSF, IL-2 (10' U/mL), or a combination of GM-CSF and IL-2 in a large population of normal donors (Fig 1B) . We first observed that some subjects were low-responders to GM-CSF, with a stimulation index less than 3 (n = 14), whereas others were either intermediate-(n = 21) or high-(n = 20) responders with indices between 3 and 5 or above 5 , respectively.
Again, IL-2 alone had minimal effects on the induction of RNA synthesis in all three groups. However, IL-2 significantly enhanced the responses to GM-CSF in the intermediate-and high-responder groups, whereas the low-responders to GM-CSF were not influenced by IL-2. Results for the responder groups were reproducible when the donors were tested several times over a period of days ( Table 1 ). The induction of total RNA synthesis was inhibited when the cells were incubated in the presence of 5 mg/mL of actinomycin D, an inhibitor of transcription (results not shown). Finally, we tested IL-2 in combination with either TNF-a or fMLP, both neutrophil agonists that markedly affect gene expression in this cell type." In contrast with the data obtained with GM-CSF, no major effect on the induction of RNA synthesis resulted from combining IL-2 with either TNF-a or fMLP ( Table 2) . were analyzed by two-dimensional gel electrophoresis and fluorography (Fig 2A and B) . However, before loading on the gels, the labeled proteins were precipitated from cell supernatants and lysates with 70% ethanol, and total counts were compared with those obtained from unstimulated cells and GM-CSF-or IL-2-stimulated cells. As in the RNA synthesis studies, indices of stimulation were calculated by dividing the counts obtained with stimulated cells by counts for unstimulated cells. The indices we obtained closely paralleled those of the RNA synthesis assay (data not shown), indicating that the RNA transcription was followed by translation into proteins. The fluorograms shown are representative of results obtained when studying four different subjects and were performed with cell lysates obtained from neutrophils that had been stimulated either by GM-CSF alone (Fig   2A) or by the combination of GM-CSF + IL-2 (Fig 2B) . It should be noted that the results shown in Fig 2A and 
IL-2R expression on neutrophils.
We next compared, by flow cytometry, expression of the IL-2R complex on unstimulated and GM-CSF-stimulated neutrophils using monoclonal antibodies to the human (Y and p chains of the IL-2R complex (Fig 3) . As previously reported, we observed that the (Y chain was undetectable ( < l % of positive cells) and that -70% of cells were positive for the p chain? The mean log fluorescence intensity measured with unstimulated and GM-CSF-stimulated cells was quite stable for both chains. These findings show that GM-CSF-treatment of neutrophils does not affect the proportion of neutrophils expressing IL-2R or the level of expression.
We next compared IL-2 binding on unstimulated and GM-CSF-stimulated neutrophils using flow cytometry (Fig 3) . Although the chain of the IL-2R complex is expressed on more than 70% of neutrophils, fewer than 20% of unstimulated neutrophils bind IL-2. However, after GM-CSF stimuFor personal use only. on January 1, 2018. by guest www.bloodjournal.org From 
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Total RNA synthesis assay as described in Materials and Methods.
lation, the population of neutrophils capable of binding IL-2 was increased to greater than 40%, representing a mean increase of 54% in the population of GM-CSF-stimulated neutrophils capable of binding IL-2. Binding of PE-labeled IL-2 to unstimulated and GM-CSF-stimulated neutrophils was inhibited when cells were preincubated with unlabeled IL-2, showing the specificity of the flow cytometry measurements for binding to the IL-2R (Fig 4) . It should be noted that the expression of the IL-2R on only 40% of the cells does not necessarily mean that we have identified a subpopulation of IL-2 positive neutrophils. This is based on the fact that in a population of homogenous activated B lymphocytes, the PE-labeled IL-2 reagent that we have used reacted with approximately the same percentage of celkZ4 This suggests that binding of the reagent is the limiting factor and therefore, the conclusion that there exists a subpopulation of IL-2-positive neutrophils should not be made at this time.
Constitutive expression of the IL-2Ry chain in neutrophils. We next investigated the presence of the IL-2Ry chain of the IL-2R complex in neutrophils. This chain is essential, along with the b chain, to IL-2R activity. As no antibody to this chain was available, we used Northern blots to study if the mRNA corresponding to this component of the IL-2R complex is present in neutrophils, and we found that neutrophils expressed and accumulated mRNA for this protein (Fig 5) suggesting that this protein is present or has the potential to be present on the surface of these cells. However, accumulation of mRNA was not affected by stimulation of neutrophils with GM-CSF. This is in agreement with the recent work of Liu et aLZ5 Although we show only the 4-hour time point, a complete time course study at 30 minutes, 1 hour, 4 hours, and 16 hours was also performed, and no evidence of modulation of mRNA levels was obtained (results not shown).
DISCUSSION
This study, in which we analyzed the effects of IL-2 on modulating gene expression in neutrophils, was considered important for a number of reasons. First, patients undergoing IL-2 therapy for cancer show an increased susceptibility to bacterial infections, and the functional responses of neutrophils are negatively affected by this form of Second, the antitumoral effects of IL-2 are believed to be partly mediated by neutrophil^.'^"^ Third, it is now recognized that neutrophils synthesize de novo a number of hostdefense proteins when participating in both the afferent and efferent limbs of the immune response."'22 In all these instances, there is little understanding of the mechanisms involved, and the precise role of IL-2 remains undetennined. Therefore, we decided to study the effects of this cytokine on de novo RNA and protein synthesis in neutrophils with the hope of shedding additional light on the mechanisms by which this important immunomodulating molecule can influence neutrophil functions.
Although IL-2 has already been shown to induce de novo synthesis of TNFa and IL-8 by neutrophils:" we had previously observed that this interleukin exerts only weak activity in initiating the nuclear signaling events that are necessary for the general activation of the RNA and protein synthesis machinery in this cell type.I9 We demonstrated that GM-CSF, along with TNF-a and FMLP, are the only neutrophil agonists of a large array tested that possess the capacity to modulate significantly gene expression in this phagocyte." However, we now report that such an effect is observed with IL-2, but only when neutrophils are also stimulated by GM-CSF. When the incorporation of [5-3H]-uridine into total RNA was used to measure de novo RNA synthesis, IL-2 exerted a dose-dependent effect on the induction of de novo RNA synthesis in GM-CSF-treated neutrophils (Fig lA) , but it remained inactive on unstimulated or TNFa-and FMLPstimulated cells (Table 2) . Furthermore, previous reports on the induction of TNF-a and IL-8 production by IL-2 pointed out that the amount of production for these cytokines varied considerably among subject^.^^'^ We obtained similar results studying the induction of de novo RNA synthesis and have examined this phenomenon in great detail. First, we studied 55 different normal subjects and observed three distinct groups of responders to GM-CSF (Fig 1B) . We refer to them as low-, intermediate-, or high-responders based on the stimulation indices obtained with their neutrophils. Second, IL-2 increased this response to levels that were significantly greater than those observed with cells treated with GM-CSF alone. Although levels were increased by IL-2, subjects remained in the same category of response. These results strongly suggested that neutrophils isolated from different subjects vary in their responsiveness to these cytokines. However, before coming firmly to this conclusion, we conducted a study to test the reproducibility of our results. We randomly chose 12 subjects who were available for repeated testing on different days. The results showed that subjects remained essentially in the same categories of response after 
Spot number
analysis on several occasions (Table 1) . Therefore, it will be important not only to discover the molecular events responsible for the observed differences in neutrophil responsiveness between subjects, but also to determine the clinical significance of these findings in monitoring patients who receive GM-CSF or IL-2 therapy. Although the synthesis of RNA induced by IL-2 in GM-CSF-stimulated neutrophils was followed by a general enhancement of protein translation, it can not be determined with any degree of precision to what extent all the RNA synthesized resulted in mRNA and protein synthesis. However, protein synthesis was clearly observed after the analysis of two-dimensional gels and the scanning of the fluorograms obtained with these gels (Fig 2) . In addition to this general enhancement, selective proteins were also either induced or inhibited by the combination of GM-CSF and IL-2. Therefore, gene expression is not only enhanced, but also modulated. Furthermore, as it was previously reported that production of TNF-a and IL-8 was induced by IL-2,9."' we measured their production by enzyme-linked immunosorbent assay (ELISA) in both the intracellular and secreted forms under our experimental conditions, and found no further induction or inhibition by the GM-CSF and IL-2 combination compared with IL-2-stimulated cells (unpublished data). This finding also argues in favor of selective modulation of gene expression when these cytokines are combined. Because GM-CSF and IL-2 are likely to be present simultaneously at sites of inflammation in vivo, our findings are biologically relevant and need to be explored fully as to their significance. In the future, it will be important to identify the nature of the proteins affected by IL-2 and to characterize their effects on neutrophil functions.
We next studied IL-2R expression and the binding of IL-2 to its receptor on GM-CSF-stimulated cells in an attempt to characterize some of the events that might explain our findings. We first confirmed that the a chain of the IL-2R complex is undetectable on human neutrophils while the 0 chain is present' (Fig 3) . However, the levels of expression of these molecules were not influenced by GM-CSF stimulation of the cells, suggesting that an increase in the number of IL-2R expressed on these cells is not the mechanism by which neutrophils are rendered more responsive to IL-2 by GM-CSF. However, the binding of IL-2 to this receptor was clearly increased by GM-CSF stimulation, suggesting that functional activation of the receptor, rather than upregulation, is at play (Fig 4) . Finally, it has been reported that, for the L-2R complex to be functional, the recently identified y chain of this receptor must be present along with the 0 chain.'"'' By Northern blots, we were able to show that human neutrophils express constitutively the y chain mRNA and thus have the potential of expressing a functional IL-2R complex as recently described.2s
We conclude that by stimulating neutrophils with GM-CSF, but not with TNF-a or FMLP, the By receptor complex expressed on these cells is functionally more active in binding IL-2. The increased binding of this cytokine to its receptor results in a general enhancement of gene expression in neutrophils along with the modulation of synthesis of selective proteins. Our findings may form the basis for studies For personal use only. on January 1, 2018. by guest www.bloodjournal.org From that could lead to a better understanding of IL-2-neutrophil interactions.
